ReviewBreast cancer (Dove Medical Press)2021

Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data.

Megan Jagosky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.